Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.06B |
| 3 |
GE HealthCare
GEHC
|
+$519M |
| 4 |
Danaher
DHR
|
+$420M |
| 5 |
American Electric Power
AEP
|
+$387M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$941M |
| 2 |
Boeing
BA
|
+$880M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$819M |
| 4 |
Bank of America
BAC
|
+$705M |
| 5 |
Coca-Cola
KO
|
+$684M |
Sector Composition
| 1 | Healthcare | 16.71% |
| 2 | Technology | 14.92% |
| 3 | Financials | 12.44% |
| 4 | Consumer Discretionary | 11.46% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Xenon Pharmaceuticals
XENE
$2.85B
| $23.1M | ﹤0.01% |
687,088
+359,785
| +110% | +$12.1M |
|
802
Quest Diagnostics
DGX
$20.3B
| $23M | ﹤0.01% |
+136,043
| New | +$23M |
|
803
AngloGold Ashanti
AU
$32.3B
| $23M | ﹤0.01% |
618,601
-235,737
| -28% | -$8.75M |
|
804
GE Vernova
GEV
$173B
| $22.9M | ﹤0.01% |
75,138
-433,449
| -85% | -$132M |
|
805
Equinox Gold
EQX
$8.42B
| $22.9M | ﹤0.01% |
3,328,440
+2,143,954
| +181% | +$14.8M |
|
806
ScottsMiracle-Gro
SMG
$3.51B
| $22.8M | ﹤0.01% |
416,049
+242,540
| +140% | +$13.3M |
|
807
Astera Labs
ALAB
$36.8B
| $22.8M | ﹤0.01% |
382,452
+271,702
| +245% | +$16.2M |
|
808
Warby Parker
WRBY
$3.31B
| $22.8M | ﹤0.01% |
1,251,492
+831,921
| +198% | +$15.2M |
|
809
Brookfield
BN
$100B
| $22.8M | ﹤0.01% |
434,873
-331,494
| -43% | -$17.4M |
|
810
Haemonetics
HAE
$2.61B
| $22.8M | ﹤0.01% |
358,180
+168,736
| +89% | +$10.7M |
|
811
QuidelOrtho
QDEL
$1.94B
| $22.7M | ﹤0.01% |
649,925
-39,700
| -6% | -$1.39M |
|
812
Winnebago Industries
WGO
$969M
| $22.7M | ﹤0.01% |
657,690
-26,698
| -4% | -$920K |
|
813
Blackstone Mortgage Trust
BXMT
$3.45B
| $22.6M | ﹤0.01% |
1,131,378
+598,781
| +112% | +$12M |
|
814
Bath & Body Works
BBWI
$5.81B
| $22.6M | ﹤0.01% |
746,005
-1,261,627
| -63% | -$38.3M |
|
815
Valaris
VAL
$3.62B
| $22.6M | ﹤0.01% |
575,676
+121,099
| +27% | +$4.75M |
|
816
Solventum
SOLV
$12.6B
| $22.6M | ﹤0.01% |
296,751
+295,764
| +29,966% | +$22.5M |
|
817
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $22.6M | ﹤0.01% |
272,753
+120,049
| +79% | +$9.93M |
|
818
Energy Select Sector SPDR Fund
XLE
$26.9B
| $22.4M | ﹤0.01% |
239,799
-12,316
| -5% | -$1.15M |
|
819
Suncor Energy
SU
$50.4B
| $22.4M | ﹤0.01% |
578,347
-176,910
| -23% | -$6.85M |
|
820
Ingersoll Rand
IR
$31.9B
| $22.4M | ﹤0.01% |
279,814
-239,744
| -46% | -$19.2M |
|
821
Equifax
EFX
$31.2B
| $22.3M | ﹤0.01% |
91,611
-153,168
| -63% | -$37.3M |
|
822
Patterson-UTI
PTEN
$2.12B
| $22.1M | ﹤0.01% |
2,690,480
+2,350,468
| +691% | +$19.3M |
|
823
Enliven Therapeutics
ELVN
$1.18B
| $22.1M | ﹤0.01% |
1,123,138
-615,394
| -35% | -$12.1M |
|
|
XHR
824
Xenia Hotels & Resorts
XHR
$1.38B
| $22M | ﹤0.01% |
1,867,589
+1,459,530
| +358% | +$17.2M |
|
825
Ryanair
RYAAY
$31.4B
| $22M | ﹤0.01% |
518,273
+510,898
| +6,927% | +$21.6M |
|